Centessa Pharmaceuticals's total assets for Q2 2025 were $492.13M, a decrease of -6.77% from the previous quarter. CNTA total liabilities were $147.21M for the fiscal quarter, a 3.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.